Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-01

Clinical Trial Update: Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia [Phase 3]

View source ↗

Summary

Phase 3 trial in Malaysia comparing artemether-lumefantrine with chloroquine for uncomplicated Plasmodium vivax malaria; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Coartem (artemether-lumefantrine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Plasmodium Vivax Malaria Without Complication | Phase 3 | Status: UNKNOWN